These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25428235)

  • 1. The impact of renin-angiotensin-aldosterone system blockade on contrast-induced nephropathy: a meta-analysis of 12 studies with 4,493 patients.
    Jo SH; Lee JM; Park J; Kim HS
    Cardiology; 2015; 130(1):4-14. PubMed ID: 25428235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of renin-angiotensin-aldosterone blockade by angiotensin-converting enzyme inhibitors or AT-1 blockers on frequency of contrast medium-induced nephropathy: a post-hoc analysis from the Dialysis-versus-Diuresis (DVD) trial.
    Kiski D; Stepper W; Brand E; Breithardt G; Reinecke H
    Nephrol Dial Transplant; 2010 Mar; 25(3):759-64. PubMed ID: 19903660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of RAAS Blockers on Contrast-Induced Nephropathy in Patients With Renal Insufficiency: A Meta-Analysis.
    Huang Y; Zhang S; Liu M; Zhong X; Lin Y; Xiong Z; Fan Y; Zhou H; Sun X; Guo Y; Xu X; Li Y; Yang D; Zhuang X; Liao X
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):692-697. PubMed ID: 32889964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between renin-angiotensin-aldosterone system blockade and contrast-induced nephropathy: an unresolved issue.
    Balta S; Aparci M
    Cardiology; 2015; 130(1):1-3. PubMed ID: 25428132
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients [corrected].
    Barış N; Özpelit E; Doğan NB; Kangül H; Gül S; Akdeniz B; Güneri S
    Anadolu Kardiyol Derg; 2013 May; 13(3):245-50. PubMed ID: 23261803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Spatz C; Saadulla L; Lapsiwala A; Parhizgar A; Ghahramani N
    Iran J Kidney Dis; 2012 Nov; 6(6):432-6. PubMed ID: 23146980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis.
    Wu Z; Zhang H; Jin W; Liu Y; Lu L; Chen Q; Zhang R
    PLoS One; 2015; 10(6):e0129747. PubMed ID: 26083525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in contrast-induced nephropathy.
    Zhou L; Duan S
    Kidney Blood Press Res; 2013; 38(2-3):165-71. PubMed ID: 24686005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does renin-angiotensin aldosterone system blockade exacerbate contrast-induced nephropathy in patients with chronic kidney disease? A prospective 50-month Mayo Clinic study.
    Onuigbo MA; Onuigbo NT
    Ren Fail; 2008; 30(1):67-72. PubMed ID: 18197546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast growth factor 23 and the antiproteinuric response to dietary sodium restriction during renin-angiotensin-aldosterone system blockade.
    Humalda JK; Lambers Heerspink HJ; Kwakernaak AJ; Slagman MC; Waanders F; Vervloet MG; Ter Wee PM; Navis G; de Borst MH;
    Am J Kidney Dis; 2015 Feb; 65(2):259-66. PubMed ID: 25278093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renoprevention revisited--The impact of preemptive withdrawal of RAAS blockade prior to iodinated contrast exposure in older CKD patients: results of a new meta-analysis.
    Onuigbo MA
    Cardiology; 2015; 130(1):25-6. PubMed ID: 25471399
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triple pharmacological blockade of the renin-angiotensin-aldosterone system in nondiabetic CKD: an open-label crossover randomized controlled trial.
    Tylicki L; Rutkowski P; Renke M; Larczyński W; Aleksandrowicz E; Lysiak-Szydlowska W; Rutkowski B
    Am J Kidney Dis; 2008 Sep; 52(3):486-93. PubMed ID: 18423812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes.
    Ma M; Wan X; Gao M; Pan B; Chen D; Sun Q; Zhang M; Zhou C; Li T; Pan H; Shao W; Liu Z; Chen Y; Cao C
    Aging (Albany NY); 2020 Apr; 12(7):5858-5877. PubMed ID: 32241961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intensity of hydration changes the role of renin-angiotensin-aldosterone system blockers in contrast-induced nephropathy risk after coronary catheterisation in patients with chronic kidney disease.
    Guo XS; Wu DX; Bei WJ; Li HL; Wang K; Zhou YL; Duan CY; Chen SQ; Lian D; Li LW; Liu Y; Tan N; Chen JY
    J Renin Angiotensin Aldosterone Syst; 2017; 18(2):1470320317708894. PubMed ID: 28490226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of acute kidney injury in coronavirus disease patients with renin-angiotensin-aldosterone-system blockade use: a systematic review and meta-analysis.
    Lee SA; Park R; Yang JH; Min IK; Park JT; Han SH; Kang SW; Yoo TH
    Sci Rep; 2021 Jun; 11(1):13588. PubMed ID: 34193877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Worsening renal failure in older chronic kidney disease patients with renal artery stenosis concurrently on renin angiotensin aldosterone system blockade: a prospective 50-month Mayo-Health-System clinic analysis.
    Onuigbo MA; Onuigbo NT
    QJM; 2008 Jul; 101(7):519-27. PubMed ID: 18375475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
    Lambers Heerspink HJ
    Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.